肺部有机体在传染性呼吸道疾病中的研究进展
Jun Li1, Wendong Yang2, Xiaoli Liu3
1Department of Clinical Pharmacy, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
European journal of pharmacology
|September 28, 2025
概括
肺部有机体为研究呼吸道感染提供了先进的3D模型,改进了传统方法. 这篇评论强调了它们在了解疾病和查药物中对流感等疾病的使用.
科学领域:
- 生物医学研究生物医学研究
- 传染病建模 传染病建模
- 干细胞技术 干细胞技术
背景情况:
- 传染性呼吸道疾病带来了重大的公共卫生挑战,需要改进的研究模式.
- 传统的模型,如动物研究和二维文化,在准确反映人类生理学方面存在局限性.
- 有机器人,体外3D组织类型,已经成为疾病建模的强大工具.
研究的目的:
- 审查肺器官技术在传染性呼吸道疾病研究方面的进展.
- 探索肺部有机体的应用,以了解病原和宿主病毒相互作用.
- 用肺器官模型总结治疗药物查方面的进展.
主要方法:
- 过去七年来科学文献的综述,重点关注肺部有机体的开发和应用.
- 对肺器官的分化培养过程的分析.
- 评估利用肺部有机物来研究传染病机制和药物疗效的研究.
主要成果:
- 与传统方法相比,肺器官提供了更准确的人类肺生理和病理的体外模型.
- 机器人便于详细研究病毒与宿主相互作用以及呼吸道感染中的致病机制.
- 在使用肺器官物质进行针对呼吸道病原体的高通量药物查方面取得了重大进展.
结论:
- 肺部有机体代表了研究传染性呼吸道疾病的变革性技术,提供了更高的复杂性和人类相关性.
- 继续开发肺部有机体模型对于提高我们对流感等疾病的理解以及发现新疗法至关重要.
- 未来的方向包括改进有机体技术,以实现更复杂的疾病建模和个性化医疗方法.
更多相关视频
10:12Establishing Human Lung Organoids and Proximal Differentiation to Generate Mature Airway Organoids
Published on: March 23, 2022
9.6K
10:30Author Spotlight: Developing a Microfluidic Lung-on-Chip Model for In-Depth Study of Human Immune Response and Infection Mechanisms
Published on: May 31, 2024
2.1K
相关概念视频
COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps:
Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
